Francis Leonard
Equibles does not estimate personal net worth.
About Francis Leonard
NovoCure Ltd reported in an 8-K filed June 6, 2025 that Francis Leonard was appointed President, Novocure, effective June 4, 2025. The proxy statement of NovoCure Ltd reports total compensation of $5,823,930 for Francis Leonard in fiscal 2024, including a base salary of $525,000. Disclosed compensation is on record for 3 fiscal years.
“In connection with his appointment of the title "President, Novocure" on June 4, 2025 (the "Award Date"), Francis Leonard, formerly the Company's Executive Vice President, President Novocure Oncology, was awarded 179,426 Restricted Share Units pursuant to the Company's 2024 Omnibus Incentive Plan ("RSUs") which will vest and convert into the Company's Ordinary Shares in equal installments on the first and second anniversaries of the Grant Date, so long as Mr. Leonard remains an employee of the Company on such dates.”
Affiliation history
-
NovoCure Ltd (NVCR)
Proxy statement
Start not stated–2025-04-21
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | NovoCure Ltd (NVCR) | Executive Vice President President Novocure US | $525,000 | $5,823,930 |
| 2023 | NovoCure Ltd (NVCR) | Executive Vice President President Novocure US | $475,000 | $5,039,237 |
| 2022 | NovoCure Ltd (NVCR) | Executive Vice President President Novocure US | $475,000 | $6,125,806 |